HMGB1 and Sepsis: Heparin has also been shown to reduce the release of HMGB1, a potent mediator of inflammation and immune response, as demonstrated by Lu et al. (2014) and Ni et al. (2020), thus potentially alleviating the exaggerated inflammatory response characteristic of sepsis.